...
search icon
ormp-img

Oramed Pharmaceuticals Inc, Common Stock

ORMP

NAQ

$2.4

-$0.05

(-2.04%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$96.75M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
4.549
Volume info-icon
This is the total number of shares traded during the most recent trading day.
126.56K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.77
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2 L
$3.67 H
$2.4

About Oramed Pharmaceuticals Inc, Common Stock

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameORMPSectorS&P500
1-Week Return10.6%-0.03%1.53%
1-Month Return1.69%4.56%4.75%
3-Month Return2.78%1.29%2.77%
6-Month Return7.14%-3.54%12.18%
1-Year Return-23.32%1.59%22.34%
3-Year Return-78%13.55%38.91%
5-Year Return-50.52%40.85%80.7%
10-Year Return-46.67%105.52%190.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.70M2.71M2.70M2.70M1.34M[{"date":"2019-12-31","value":99.74,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.74,"profit":true},{"date":"2022-12-31","value":99.74,"profit":true},{"date":"2023-12-31","value":49.45,"profit":true}]
Cost of Revenue90.00K90.00K---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit2.61M2.62M2.70M2.70M1.34M[{"date":"2019-12-31","value":96.67,"profit":true},{"date":"2020-12-31","value":96.93,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":49.57,"profit":true}]
Gross Margin96.67%96.68%100.00%100.00%100.00%[{"date":"2019-12-31","value":96.67,"profit":true},{"date":"2020-12-31","value":96.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses17.24M14.47M26.93M43.30M17.11M[{"date":"2019-12-31","value":39.82,"profit":true},{"date":"2020-12-31","value":33.41,"profit":true},{"date":"2021-12-31","value":62.18,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":39.51,"profit":true}]
Operating Income(14.63M)(11.76M)(24.22M)(40.60M)(15.77M)[{"date":"2019-12-31","value":-1463100000,"profit":false},{"date":"2020-12-31","value":-1175700000,"profit":false},{"date":"2021-12-31","value":-2422300000,"profit":false},{"date":"2022-12-31","value":-4059800000,"profit":false},{"date":"2023-12-31","value":-1576900000,"profit":false}]
Total Non-Operating Income/Expense-246.00K1.23M6.50M25.45M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.97,"profit":true},{"date":"2021-12-31","value":4.85,"profit":true},{"date":"2022-12-31","value":25.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(14.05M)(11.51M)(22.99M)(37.66M)5.09M[{"date":"2019-12-31","value":-276.24,"profit":false},{"date":"2020-12-31","value":-226.24,"profit":false},{"date":"2021-12-31","value":-451.83,"profit":false},{"date":"2022-12-31","value":-740.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes300.00K192.00K(2.88M)100.00K-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":64,"profit":true},{"date":"2021-12-31","value":-959.33,"profit":false},{"date":"2022-12-31","value":33.33,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-(11.70M)(20.11M)(37.76M)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1170300000,"profit":false},{"date":"2021-12-31","value":-2011100000,"profit":false},{"date":"2022-12-31","value":-3776400000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(11.51M)(22.99M)(37.76M)5.09M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-226.24,"profit":false},{"date":"2021-12-31","value":-451.83,"profit":false},{"date":"2022-12-31","value":-742.22,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.36M)(11.51M)(22.24M)(37.76M)5.53M[{"date":"2019-12-31","value":-259.82,"profit":false},{"date":"2020-12-31","value":-208.34,"profit":false},{"date":"2021-12-31","value":-402.5,"profit":false},{"date":"2022-12-31","value":-683.51,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)(0.72)(0.66)(0.77)(0.94)0.14[{"date":"2019-12-31","value":-514.29,"profit":false},{"date":"2020-12-31","value":-471.43,"profit":false},{"date":"2021-12-31","value":-550,"profit":false},{"date":"2022-12-31","value":-671.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ORMP
Cash Ratio 26.99
Current Ratio 27.08

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ORMP
ROA (LTM) -4.12%
ROE (LTM) 2.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ORMP
Debt Ratio Lower is generally better. Negative is bad. 0.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ORMP
Trailing PE 4.55
Forward PE NM
P/S (TTM) 141.54
P/B 0.62
Price/FCF NM
EV/R 2.86
EV/Ebitda 0.52
PEG NM

FAQs

What is Oramed Pharmaceuticals Inc share price today?

Oramed Pharmaceuticals Inc (ORMP) share price today is $2.4

Can Indians buy Oramed Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Oramed Pharmaceuticals Inc (ORMP) on Vested. To buy Oramed Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ORMP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Oramed Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Oramed Pharmaceuticals Inc (ORMP) via the Vested app. You can start investing in Oramed Pharmaceuticals Inc (ORMP) with a minimum investment of $1.

How to invest in Oramed Pharmaceuticals Inc shares from India?

You can invest in shares of Oramed Pharmaceuticals Inc (ORMP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ORMP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Oramed Pharmaceuticals Inc shares
What is Oramed Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Oramed Pharmaceuticals Inc (ORMP) is $3.67. The 52-week low price of Oramed Pharmaceuticals Inc (ORMP) is $2.

What is Oramed Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Oramed Pharmaceuticals Inc (ORMP) is 4.549

What is Oramed Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Oramed Pharmaceuticals Inc (ORMP) is 0.62

What is the Market Cap of Oramed Pharmaceuticals Inc?

The market capitalization of Oramed Pharmaceuticals Inc (ORMP) is $96.75M

What is Oramed Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Oramed Pharmaceuticals Inc is ORMP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top